Assyro AI

Orange Book product · Brand (NDA)

PENNSAID

DICLOFENAC SODIUM

Brand (NDA)NDA 020947DISCN NUVO PHARMS INC

At a glance

Nov 04, 2009

Approved

Brand (NDA)

Application

Not listed

TE code

5

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 04, 2009

    16 yr 10 mo ago

  2. Today

  3. Patent 8217078 expires

    Listed method-of-use patent (U-1248) expiration.

    Jul 10, 2029

    in 3 yr 1 mo

  4. Patent 8618164 expires

    Listed method-of-use patent (U-1477) expiration.

    Jul 10, 2029

    in 3 yr 1 mo

  5. Patent 8741956 expires

    Listed method-of-use patent (U-1435) expiration.

    Jul 10, 2029

    in 3 yr 1 mo

  6. Patent 8546450 expires

    Listed method-of-use patent (U-1435) expiration.

    Aug 09, 2030

    in 4 yr 2 mo

  7. Patent 8546450 expires

    Listed method-of-use patent (U-1436) expiration.

    Aug 09, 2030

    in 4 yr 2 mo

Pharmaceutical detail

Active ingredient

DICLOFENAC SODIUM

Strength

1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

SOLUTION

Route

TOPICAL

TE code

Not listed

Application

NDA 020947

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (5)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8217078Jul 10, 2029in 3 yr 1 mo
U-1248
8618164Jul 10, 2029in 3 yr 1 mo
U-1477
8741956Jul 10, 2029in 3 yr 1 mo
U-1435
8546450Aug 09, 2030in 4 yr 2 mo
U-1435
8546450Aug 09, 2030in 4 yr 2 mo
U-1436
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.